Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes.

DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ.

Transplant Direct. 2019 May 22;5(6):e456. doi: 10.1097/TXD.0000000000000900. eCollection 2019 Jun.

2.

Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipient.

Fu W, Merola J, Malinis M, Lacy J, Barbieri A, Liapakis AH, Mulligan DC, Yoo PS.

Transpl Infect Dis. 2018 Oct;20(5):e12966. doi: 10.1111/tid.12966. Epub 2018 Aug 23.

PMID:
30014622
3.

Modulation of Intestinal Microbiome Prevents Intestinal Ischemic Injury.

Bertacco A, Dehner CA, Caturegli G, D'Amico F, Morotti R, Rodriguez MI, Mulligan DC, Kriegel MA, Geibel JP.

Front Physiol. 2017 Dec 19;8:1064. doi: 10.3389/fphys.2017.01064. eCollection 2017.

4.

Allograft transmission of hepatitis C during the window period: Weighing the new risks and costs in the era of donor shortage.

Choe J, Merola J, Kulkarni S, Mulligan DC.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13022. Epub 2017 Jun 23. No abstract available.

PMID:
28643333
5.

Liver retransplantation: Recurrent primary sclerosing cholangitis may provide better outcomes.

Choe J, Mulligan DC.

Liver Transpl. 2017 Jun;23(6):730-732. doi: 10.1002/lt.24777. No abstract available.

6.

Predictors of Waitlist Mortality in Portopulmonary Hypertension.

DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN.

Transplantation. 2017 Jul;101(7):1609-1615. doi: 10.1097/TP.0000000000001666.

7.

Changes in united network for organ sharing policy for simultaneous liver-kidney allocation.

Merola J, Formica RN, Mulligan DC.

Clin Liver Dis (Hoboken). 2017 Feb 3;9(1):21-24. doi: 10.1002/cld.609. eCollection 2017 Jan. Review. No abstract available.

8.

Postoperative delirium is associated with increased intensive care unit and hospital length of stays after liver transplantation.

Bhattacharya B, Maung A, Barre K, Maerz L, Rodriguez-Davalos MI, Schilsky M, Mulligan DC, Davis KA.

J Surg Res. 2017 Jan;207:223-228. doi: 10.1016/j.jss.2016.08.084. Epub 2016 Sep 2.

PMID:
27979481
9.

Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.

Merola J, Yoo PS, Schaub J, Smith JD, Rodriguez-Davalos MI, Tichy E, Mulligan DC, Asch W, Formica R, Kashgarian M, Kulkarni S.

Transplant Proc. 2016 Nov;48(9):3106-3108. doi: 10.1016/j.transproceed.2016.04.005.

PMID:
27932157
10.

Attitudes toward organ donation among waitlisted transplant patients: results of a cross-sectional survey.

Merola J, Pei KY, Rodriguez-Davalos MI, Gan G, Deng Y, Mulligan DC, Davis KA.

Clin Transplant. 2016 Nov;30(11):1449-1456. doi: 10.1111/ctr.12839. Epub 2016 Sep 29.

11.

Partners in Crime: Kidney Transplantation and Seizure Disorder.

Li N, Jean R, Tooley JE, Mulligan DC, Yoo PS.

Transplant Proc. 2016 Oct;48(8):2700-2708. doi: 10.1016/j.transproceed.2016.06.041.

PMID:
27788804
12.

The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.

Mulligan DC.

Hepatology. 2016 Dec;64(6):1853-1855. doi: 10.1002/hep.28841. Epub 2016 Oct 25. No abstract available.

PMID:
27641833
13.

Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.

Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK.

Transplantation. 2016 Oct;100(10):2153-9. doi: 10.1097/TP.0000000000001384.

14.

Perioperative outcomes of coronary artery bypass graft in renal transplant recipients in the United States: results from the Nationwide Inpatient Sample.

Tooley JE, Bohl DD, Kulkarni S, Rodriguez-Davalos MI, Mangi A, Mulligan DC, Yoo PS.

Clin Transplant. 2016 Oct;30(10):1258-1263. doi: 10.1111/ctr.12816. Epub 2016 Sep 25.

PMID:
27440000
15.

The impact of broader regional sharing of livers: 2-year results of "Share 35".

Edwards EB, Harper AM, Hirose R, Mulligan DC.

Liver Transpl. 2016 Apr;22(4):399-409. doi: 10.1002/lt.24418.

16.

Increasing the Number of Organs Available to Transplant Is Separate From Ensuring Equitable Distribution of Available Organs: Both Are Important Goals.

Hirose R, Gentry SE, Mulligan DC.

Am J Transplant. 2016 Feb;16(2):728-9. doi: 10.1111/ajt.13577. Epub 2016 Jan 12. No abstract available.

17.

Extracorporeal Hypothermic Perfusion Device for Intestinal Graft Preservation to Decrease Ischemic Injury During Transportation.

Muñoz-Abraham AS, Patrón-Lozano R, Narayan RR, Judeeba SS, Alkukhun A, Alfadda TI, Belter JT, Mulligan DC, Morotti R, Zinter JP, Geibel JP, Rodríguez-Dávalos MI.

J Gastrointest Surg. 2016 Feb;20(2):313-21.

PMID:
26487331
18.

Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity.

Gentry SE, Segev DL, Kasiske BL, Mulligan DC, Hirose R.

Transplantation. 2015 Sep;99(9):e159-60. doi: 10.1097/TP.0000000000000834. No abstract available.

19.

Non-alcoholic fatty liver disease following liver transplantation: a clinical review.

Merola J, Liapakis A, Mulligan DC, Yoo PS.

Clin Transplant. 2015 Sep;29(9):728-37. doi: 10.1111/ctr.12585. Epub 2015 Aug 11. Review.

PMID:
26147308
20.

Early changes in liver distribution following implementation of Share 35.

Massie AB, Chow EK, Wickliffe CE, Luo X, Gentry SE, Mulligan DC, Segev DL.

Am J Transplant. 2015 Mar;15(3):659-67. doi: 10.1111/ajt.13099.

21.

Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation.

Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE.

Abdom Imaging. 2015 Apr;40(4):795-802. doi: 10.1007/s00261-014-0310-y.

PMID:
25445158
22.

Robotic resection of choledochocele in an adult with intracorporeal hepaticojejunostomy and Roux-en-Y anastomosis: encouraging progress for robotic surgical treatment of biliary disease.

Carpenter SG, Grimsby G, DeMasters T, Katariya N, Hewitt WR, Moss AA, Reddy KS, Castle EP, Mulligan DC.

J Robot Surg. 2014 Mar;8(1):77-80. doi: 10.1007/s11701-012-0389-5. Epub 2012 Dec 27.

PMID:
27637243
23.

Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer.

Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M.

J Gastrointest Oncol. 2013 Dec;4(4):352-60. doi: 10.3978/j.issn.2078-6891.2013.006.

24.

New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.

Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ.

J Transplant. 2013;2013:269096. doi: 10.1155/2013/269096. Epub 2013 Sep 24.

25.

Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.

Chakkera HA, Chang YH, Bodner JK, Behmen S, Heilman RL, Reddy KS, Mulligan DC, Moss AA, Khamash H, Katariya N, Hewitt WR, Pitta TL, Frassetto LA.

Transplant Proc. 2013 Jan-Feb;45(1):137-41. doi: 10.1016/j.transproceed.2012.10.023.

PMID:
23375287
26.

Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy.

Hsieh TH, Mekeel KL, Crowell MD, Nguyen CC, Das A, Aqel BA, Carey EJ, Byrne TJ, Vargas HE, Douglas DD, Mulligan DC, Harrison ME.

Gastrointest Endosc. 2013 Jan;77(1):47-54. doi: 10.1016/j.gie.2012.08.034. Epub 2012 Oct 11.

PMID:
23062758
27.

Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation.

Martin AD, Mekeel KL, Castle EP, Vaish SS, Martin GL, Moss AA, Mulligan DC, Heilman RL, Reddy KS, Andrews PE.

BJU Int. 2012 Dec;110(11 Pt C):E1003-7. doi: 10.1111/j.1464-410X.2012.11379.x. Epub 2012 Aug 9.

28.

Living donor safety during the performance of hepatectomy.

Mulligan DC.

Liver Transpl. 2012 Oct;18(10):1134-5. doi: 10.1002/lt.23514. No abstract available.

29.

Ureteral stricture formation in laparoscopically procured living donor kidney transplantation.

Tyson MD, Castle EP, Andrews PE, Heilman RL, Moss AA, Mulligan DC, Reddy KS.

Can J Urol. 2012 Apr;19(2):6188-92.

PMID:
22512964
30.

A consolidated biovigilance system for blood, tissue and organs: one size does not fit all.

Pruett TL, Blumberg EA, Cohen DJ, Crippin JS, Freeman RB, Hanto DW, Mulligan DC, Green MD.

Am J Transplant. 2012 May;12(5):1099-101. doi: 10.1111/j.1600-6143.2011.03907.x. Epub 2012 Apr 9.

31.

Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation.

Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA.

J Transplant. 2012;2012:614781. doi: 10.1155/2012/614781. Epub 2012 Jan 29.

32.

Laparoscopic distal pancreatectomy: does splenic preservation affect outcomes?

Mekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL.

Surg Laparosc Endosc Percutan Tech. 2011 Oct;21(5):362-5. doi: 10.1097/SLE.0b013e31822e0ea8.

PMID:
22002275
33.

Pretransplant risk score for new-onset diabetes after kidney transplantation.

Chakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC.

Diabetes Care. 2011 Oct;34(10):2141-5. doi: 10.2337/dc11-0752.

34.

A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.

Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG.

Liver Transpl. 2011 Dec;17(12):1394-403. doi: 10.1002/lt.22417.

35.

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.

Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.

Transplantation. 2011 Sep 15;92(5):570-4. doi: 10.1097/TP.0b013e318225db2c.

PMID:
21712755
36.

A technique for kidney retransplantation after simultaneous kidney pancreas transplantation.

Mekeel KL, Moss AA, Mulligan DC, Reddy KS.

Transplant Proc. 2011 Jun;43(5):1627-8. doi: 10.1016/j.transproceed.2011.03.026.

PMID:
21693246
37.

Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal.

Heilman RL, Nijim S, Chakkera HA, Devarapalli Y, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS.

J Transplant. 2011;2011:583981. doi: 10.1155/2011/583981. Epub 2011 May 15.

38.

Open sphincteroplasty for benign ampullary stricture after pancreas transplantation.

Mekeel KL, Moss AA, Mulligan DC, Reddy KS.

Am J Transplant. 2011 Feb;11(2):399-402. doi: 10.1111/j.1600-6143.2010.03369.x. Epub 2011 Jan 7.

39.

Living donor kidney transplantation with multiple renal arteries in the laparoscopic era.

Tyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS.

Urology. 2011 May;77(5):1116-21. doi: 10.1016/j.urology.2010.07.503. Epub 2010 Dec 8.

PMID:
21145095
40.

Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus.

Chakkera HA, Bodner JK, Heilman RL, Mulligan DC, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Ray RM, Beck GL, Reddy KS.

Transplant Proc. 2010 Sep;42(7):2650-2. doi: 10.1016/j.transproceed.2010.04.065.

41.

Short-term cardiac and noncardiac mortality following liver transplantation.

Eleid MF, Hurst RT, Vargas HE, Rakela J, Mulligan DC, Appleton CP.

J Transplant. 2010;2010. pii: 910165. doi: 10.1155/2010/910165. Epub 2010 Aug 12.

42.

Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus.

Chakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1669-75. doi: 10.2215/CJN.09481209. Epub 2010 Jun 17.

43.

Successful transplantation of a split crossed fused ectopic kidney into a patient with end-stage renal disease.

Mekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Sudhakar Reddy K.

J Transplant. 2010;2010:383972. doi: 10.1155/2010/383972. Epub 2010 Mar 25.

44.

Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients.

Heilman RL, Devarapalli Y, Chakkera HA, Mekeel KL, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS.

Am J Transplant. 2010 Mar;10(3):563-70. doi: 10.1111/j.1600-6143.2009.02966.x. Epub 2010 Feb 1.

45.

Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.

Chakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, Mulligan DC, Reddy KS, Mazur MJ, Hamawi K, Moss AA, Mekeel KL, Cerhan JR.

Transplant Proc. 2009 Dec;41(10):4172-7. doi: 10.1016/j.transproceed.2009.08.063.

46.

ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation.

Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D'Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB; ASTS Standards on Organ Transplantation Committee.

Am J Transplant. 2009 Sep;9(9):2004-11. doi: 10.1111/j.1600-6143.2009.02739.x. Epub 2009 Jul 16.

47.

Deceased donor kidney transplantation from donors with acute renal failure due to rhabdomyolysis.

Mekeel KL, Moss AA, Mulligan DC, Chakkera HA, Hamawi K, Mazur MJ, Heilman RL, Reddy KS.

Am J Transplant. 2009 Jul;9(7):1666-70. doi: 10.1111/j.1600-6143.2009.02663.x. Epub 2009 May 20.

48.

Hyperglycemia during the immediate period after kidney transplantation.

Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB.

Clin J Am Soc Nephrol. 2009 Apr;4(4):853-9. doi: 10.2215/CJN.05471008. Epub 2009 Apr 1.

49.

Hemobilia and pancreatitis after liver transplant biopsy.

Li F, Mekeel KL, Eleid M, Harrison ME, Reddy KS, Moss AA, Mulligan DC.

Liver Transpl. 2009 Mar;15(3):350-1. doi: 10.1002/lt.21619. No abstract available. Erratum in: Liver Transpl. 2009 Dec;15(12):1905. Eleid, Mackam [corrected to Eleid, Mackram].

50.

Utility of the endovascular stapler for right-sided laparoscopic donor nephrectomy: a 7-year experience at Mayo Clinic.

Ko EY, Castle EP, Desai PJ, Moss AA, Reddy KS, Mekeel KL, Mulligan DC, Andrews PE.

J Am Coll Surg. 2008 Dec;207(6):896-903. doi: 10.1016/j.jamcollsurg.2008.07.013. Epub 2008 Aug 30.

PMID:
19183537

Supplemental Content

Loading ...
Support Center